Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion type Assertion NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_head.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion description "[Irinotecan (CPT-11) is a promising antitumor agent, recently approved for use in patients with metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_provenance.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion evidence source_evidence_literature NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_provenance.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion SIO_000772 9466980 NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_provenance.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion wasDerivedFrom befree-2016 NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_provenance.
- NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_assertion wasGeneratedBy ECO_0000203 NP1388783.RASXuhe1LzwJJ_XOqybKzBJvVb1fQbedun2nmrDnUpRXM130_provenance.